摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-(diethylamino)-1-benzofuran-2-carboxylic acid | 52664-54-7

中文名称
——
中文别名
——
英文名称
6-(diethylamino)-1-benzofuran-2-carboxylic acid
英文别名
6-diethylaminobenzo[b]furan-2-carboxylic acid
6-(diethylamino)-1-benzofuran-2-carboxylic acid化学式
CAS
52664-54-7
化学式
C13H15NO3
mdl
——
分子量
233.267
InChiKey
HBLWEEAIUKUJAS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.3
  • 重原子数:
    17
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.31
  • 拓扑面积:
    53.7
  • 氢给体数:
    1
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    甲基丙烯酸羟乙酯6-(diethylamino)-1-benzofuran-2-carboxylic acid4-吡咯烷基吡啶N,N'-二环己基碳二亚胺 作用下, 以 四氢呋喃 为溶剂, 反应 24.0h, 以70%的产率得到benzofuran-2-carboxylic acid 2-(2-methylacryloyloxy)ethyl ester
    参考文献:
    名称:
    Synthesis and Polymerisation of Novel Methacrylates with Carbazolyl and Benzofuranyl Pendant Groups for Photovoltaic Applications
    摘要:
    This article reports properties of photovoltaic devices containing new donor materials - copolymers referred as PCEMB, composed of 2-(carbazol-9-yl)ethyl methacrylate (CEM) and benzofuran-2-carboxylic acid 2-(2-methylacryloyloxy)ethyl ester (MB). Manufactured photovoltaic cells consisted of donor and acceptor (PBT or P3OT) layers sandwiched between ITO covered glass and evaporated aluminum electrode. Performance of the cell was optimized for a copolymer composed of 8% CEM and 92% MB. The efficiency, found equal c.a. eta = 0,03%, was low comparing to other photovoltaic cells reported in the literature. However, following the observed tendencies, it can be supposed that there exists a large reserve for the enhancement of the open circuit voltage through further chemical modifications of the chromophore.In the case of the PDT containing cells, measured Uoc was substantially lower. This fact may be attributed to difference in carrier mobility between this polymer and PCEMB. Simultaneously, the larger sizes of the MB molecule may favor separation of the charges and leads to enhancement of the corresponding voltage.
    DOI:
    10.1080/15421400801904732
  • 作为产物:
    描述:
    methyl 6-(diethylamino)-1-benzofuran-2-carboxylate 、 lithium hydroxide 作用下, 以 四氢呋喃 为溶剂, 反应 18.0h, 生成 6-(diethylamino)-1-benzofuran-2-carboxylic acid
    参考文献:
    名称:
    [EN] ACYL SULFONAMIDES FOR TREATING CANCER
    [FR] ACYLSULFONAMIDES POUR LE TRAITEMENT DU CANCER
    摘要:
    本发明提供了一般式(I)的酰基磺酰胺化合物:其中X、R1、R2、R3、R4、R5、R6、Ra和Rb如本文所述和定义的那样,制备所述化合物的方法,用于制备所述化合物的有用中间体化合物,包含所述化合物的药物组合物和组合物,以及利用所述化合物制造用于治疗或预防疾病的药物组合物,特别是治疗或预防过度增殖性疾病的药物组合物,作为唯一药剂或与其他活性成分结合使用,以及治疗和/或预防疾病的方法,特别是癌症,更特别是KAT6A和/或KAT6B在局部扩增的癌症,所述方法包括向需要的受试者施用至少一种式(I)化合物的有效量。
    公开号:
    WO2020216701A1
点击查看最新优质反应信息

文献信息

  • Linear basic compounds having nk-2 antagonist activity and formulations thereof
    申请人:——
    公开号:US20040259930A1
    公开(公告)日:2004-12-23
    Described herein are compounds of formula (I) useful as antagonists of tachykinins in general, and in particular of neurokinin A; and the pharmaceutical formulations comprising the compounds of formula (I) 1
    本文描述了式(I)化合物,可作为缓激肽拮抗剂,特别是神经激肽A的拮抗剂,并且包括含有式(I)化合物的药物制剂。
  • LINEAR BASIC COMPOUNDS HAVING NK-2 ANTAGONIST ACTIVITY AND FORMULATIONS THEREOF
    申请人:Malesci Istituto Farmacobiologico S.p.A.
    公开号:EP1442050B1
    公开(公告)日:2006-09-13
  • ACYL SULFONAMIDES FOR TREATING CANCER
    申请人:Bayer Aktiengesellschaft
    公开号:US20220226279A1
    公开(公告)日:2022-07-21
    The present invention provides acyl sulfonamide compounds of general formula (I): in which X, R 1 , R 2 , R 3 , R 4 , R 5 , R 6′ R a and R b are as described and defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds, and the use of said compounds for manufacturing pharmaceutical compositions for the treatment or prophylaxis of diseases, in particular of hyperproliferative disorders, as a sole agent or in combination with other active ingredients as well as methods of treating and/or prophylaxing diseases, particularly cancer, more particularly cancer in which KAT6A and/or KAT6B is focally amplified, said method comprising administering an effective amount of at least one compound of formula (I) to a subject in need thereof.
  • US3932446A
    申请人:——
    公开号:US3932446A
    公开(公告)日:1976-01-13
  • US7273856B2
    申请人:——
    公开号:US7273856B2
    公开(公告)日:2007-09-25
查看更多

同类化合物

顺式-1-((2-(5-氯-2-苯并呋喃基)-4-甲基-1,3-二氧戊环-2-基)甲基)-1H-1,2,4-三唑 顺式-1-((2-(5,7-二氯-2-苯并呋喃基)-4-乙基-1,3-二氧戊环-2-基)甲基)-1H-咪唑 顺式-1-((2-(2-苯并呋喃基)-4-乙基-1,3-二氧戊环-2-基)甲基)-1H-1,2,4-三唑 霉酚酸酯杂质B 间甲酚紫 间甲基苯基(苯并呋喃-2-基)甲醇 长管假茉莉素C 金霉素 酪氨酸,b-羰基- 酞酸酐-d4 酚酞二丁酸酯 酚酞 酚红钠 酚红 邻苯二甲酸酐与马来酸酐,甘氨酰蜡素和二乙二醇的聚合物 邻苯二甲酸酐与己二醇的聚合物 邻苯二甲酸酐与三甘醇异壬醇的聚合物 邻苯二甲酸酐与2-乙基-2-羟甲基-1,3-丙二醇和2,5-呋喃二酮的聚合物 邻苯二甲酸酐与2-乙基-2-羟甲基-1,3-丙二醇、2,5-呋喃二酮和2-乙基己酸苯甲酸酯的聚合物 邻苯二甲酸酐-4-硼酸频哪醇酯 邻苯二甲酸酐,马来酸,二乙二醇,新戊二醇聚合物 邻甲酚酞 贝康唑 表灰黄霉素 螺佐呋酮 螺[苯并呋喃-3(2H),4-哌啶] 螺[异苯并呋喃-1(3H),4’-哌啶]-3-酮 螺[异苯并呋喃-1(3H),4'-哌啶]-3-酮盐酸盐 螺[异苯并呋喃-1(3H),3’-吡咯烷]-3-酮 螺[1-苯并呋喃-2,1'-环丙烷]-3-酮 薄荷内酯 莫罗卡尼 荨麻叶泽兰酮 荧光胺 苯酞-3-乙酸 苯酐二乙二醇共聚物 苯酐 苯甲酸,2-[(1,3-二羰基丁基)氨基]-,甲基酯 苯甲酸,2,2-二(羟甲基)丙烷-1,3-二醇,异苯并呋喃-1,3-二酮 苯甲酰氯化,3-甲氧基-4-甲基- 苯甲基(1-{(2-amino-2-methylpropanoyl)[(2S)-2-aminopropanoyl]amino}-2-methyl-1-oxopropan-2-yl)甲基氨基甲酸酯(non-preferredname) 苯并呋喃并[3,2-d]嘧啶-2,4(1H,3H)-二酮 苯并呋喃并[3,2-D]嘧啶-4(1H)-酮 苯并呋喃并[2,3-d]哒嗪-4(3H)-酮 苯并呋喃并(3,2-c)吡啶,1,2,3,4-四氢-2-(2-(二甲氨基)乙基)-,二盐酸 苯并呋喃与1H-茚的聚合物 苯并呋喃[3,2-b]吡咯-2-羧酸 苯并呋喃-7-羧酸 苯并呋喃-7-硼酸频那醇酯 苯并呋喃-7-甲腈